John Murnane has over 35 years of experience as a litigator in patent and trade secret cases. He has appeared as lead counsel in such matters since 1986, representing clients in federal trial courts throughout the United States, in the International Trade Commission and before the Federal Circuit Court of Appeals and the USPTO Patent Trial and Appeal Board.
John has represented many companies in complex litigations involving patents in a variety of fields. Since the early 1990’s, he has advised and represented pharmaceutical and biotechnology companies in numerous matters, including litigations involving doxycycline, mutated enzymes, hormone replacement therapy, Abilify®, Sensipar®, and Plavix®. He has also been lead counsel in cases involving patents in the fields of aramid fiber products, catalyzed reactions, cellulose processing, permanent press resins, truck tires, hydrocarbon processing and building materials.
In addition to litigation, John has an extensive practice in patent counseling, opinion work, patent reexaminations, and licensing and has been responsible for supervising the patent prosecution of several major corporations. In 1997, Governor George E. Pataki appointed him to the New York State Task Force on Life and the Law, where he continues to serve. He was an Adjunct Professor of Law at Fordham University from 1989 to 1993 and at Hofstra University from 1986 to 1989. He is a past president of the New York Intellectual Property Law Association.
John is a member of the firm’s Management Committee and Chair of the Chemicals Practice Group.